MedTrace Logo

Evaluation of Effects of Exercise Training and ARB in DM Patients

NCT01053026 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2012-11-16

No results posted yet for this study

Summary

The aims of this clinical trial are to assess the impacts on vascular function tests and circulating biomarkers of a short-term (12-week) low-to-median intensity exercise training or ARBs treatment in patients with DM and hypertension.

Conditions

  • Vascular Function
  • Exercise Training

Interventions

DRUG

olmesartan

(1) Olmesartan treatment or (2) Life modification and exercise training

Sponsors & Collaborators

  • Daiichi Sankyo Taiwan Ltd.

    collaborator INDUSTRY

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Yen-Wen Wu, MD, PhD · National Taiwan University Hospital

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01053026 on ClinicalTrials.gov